Alembic Pharmaceuticals has received very last approval from the United States Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Vilazodone Hydrochloride Tablets, 10 mg, 20 mg, and forty mg. The accredited ANDA is therapeutically equal to the reference listed drug product (RLD), Viibryd Tablets, 10 mg, 20 mg, and 40 mg, of Allergan Sales, LLC (Allergan). Vilazodone Hydrochloride Tablets are indicated for the treatment of most important depressive ailment.
Vilazodone Hydrochloride Tablets, 10 mg, 20 mg, and forty mg have an envisioned market length of US$ 469 million for one year finishing September 2019 in accordance
to IQVIA.
Bazaarinformation team has many years of experience, covering the physical and future commodities markets with prominent commodity & equity trading advising which shines further with extensive network to get research from ground levels to generate proper reporting and movements. We are able to get evens out of odds in volatile markets and stockings. ...
